Patent foramen ovale and ischemic stroke: more shadows than lights? What the internist should know

Submitted: 23 November 2015
Accepted: 19 February 2016
Published: 30 September 2016
Abstract Views: 1514
PDF: 846
HTML: 923
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

The foramen ovale (FO) is an anatomical structure normally present in the fetus, which can persist in up to 25%-30% of the general population after birth. Normally it does not cause any harm but it has been associated with different pathological conditions; the more frequently encountered in clinical practice is an ischemic stroke or transient ischemic attack without any recognizable cause. However, a causal link between the cerebrovascular event and a right to left shunt through the FO is hard to demonstrate in most cases and which is the best treatment for secondary prevention is still a matter of debate with antithrombotic therapy or transcatheter closure of the FO as possible options. No definitive evidence of which is the most effective treatment is actually available so that a careful evaluation of each single patient is mandatory in order to select who will probably benefit the most from the interventional treatment as opposed to who will reasonably do well with medical therapy alone.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Donti, A. (2016). Patent foramen ovale and ischemic stroke: more shadows than lights? What the internist should know. Italian Journal of Medicine, 10(3), 175–184. https://doi.org/10.4081/itjm.2016.676